Annual CFI
-$505.00 K
-$387.00 K-327.97%
31 December 2023
Summary:
Cidara Therapeutics annual cash flow from investing activities is currently -$505.00 thousand, with the most recent change of -$387.00 thousand (-327.97%) on 31 December 2023. During the last 3 years, it has fallen by -$319.00 thousand (-171.51%). CDTX annual CFI is now -101.98% below its all-time high of $25.48 million, reached on 31 December 2016.CDTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$106.00 K
-$106.00 K-100.00%
30 September 2024
Summary:
Cidara Therapeutics quarterly cash flow from investing activities is currently -$106.00 thousand, with the most recent change of -$106.00 thousand (-100.00%) on 30 September 2024. Over the past year, it has increased by +$20.00 thousand (+15.87%). CDTX quarterly CFI is now -100.30% below its all-time high of $35.39 million, reached on 31 December 2016.CDTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$307.00 K
+$20.00 K+6.12%
30 September 2024
Summary:
Cidara Therapeutics TTM cash flow from investing activities is currently -$307.00 thousand, with the most recent change of +$20.00 thousand (+6.12%) on 30 September 2024. Over the past year, it has increased by +$29.00 thousand (+8.63%). CDTX TTM CFI is now -100.53% below its all-time high of $57.61 million, reached on 30 June 2017.CDTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDTX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -328.0% | +15.9% | +8.6% |
| 3 y3 years | -171.5% | -783.3% | -648.8% |
| 5 y5 years | -103.5% | -100.0% | -106.9% |
CDTX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1131.7% | at low | +40.5% | -648.8% | +39.2% | |
| 5 y | 5 years | -103.5% | at low | +40.5% | -106.9% | +39.2% | |
| alltime | all time | -102.0% | +98.9% | -100.3% | +99.8% | -100.5% | +99.5% |
Cidara Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$106.00 K(<-9900.0%) | -$307.00 K(-6.1%) |
| June 2024 | - | $0.00(-100.0%) | -$327.00 K(-24.7%) |
| Mar 2024 | - | -$23.00 K(-87.1%) | -$434.00 K(-14.1%) |
| Dec 2023 | -$505.00 K(+328.0%) | -$178.00 K(+41.3%) | -$505.00 K(+50.3%) |
| Sept 2023 | - | -$126.00 K(+17.8%) | -$336.00 K(+53.4%) |
| June 2023 | - | -$107.00 K(+13.8%) | -$219.00 K(+71.1%) |
| Mar 2023 | - | -$94.00 K(+944.4%) | -$128.00 K(+8.5%) |
| Dec 2022 | -$118.00 K(+187.8%) | -$9000.00(0.0%) | -$118.00 K(+8.3%) |
| Sept 2022 | - | -$9000.00(-43.8%) | -$109.00 K(-2.7%) |
| June 2022 | - | -$16.00 K(-81.0%) | -$112.00 K(-0.9%) |
| Mar 2022 | - | -$84.00 K(<-9900.0%) | -$113.00 K(+175.6%) |
| Dec 2021 | -$41.00 K(-78.0%) | $0.00(-100.0%) | -$41.00 K(0.0%) |
| Sept 2021 | - | -$12.00 K(-29.4%) | -$41.00 K(-50.6%) |
| June 2021 | - | -$17.00 K(+41.7%) | -$83.00 K(-48.8%) |
| Mar 2021 | - | -$12.00 K(<-9900.0%) | -$162.00 K(-12.9%) |
| Dec 2020 | -$186.00 K(+431.4%) | $0.00(-100.0%) | -$186.00 K(0.0%) |
| Sept 2020 | - | -$54.00 K(-43.8%) | -$186.00 K(+40.9%) |
| June 2020 | - | -$96.00 K(+166.7%) | -$132.00 K(+112.9%) |
| Mar 2020 | - | -$36.00 K(<-9900.0%) | -$62.00 K(+77.1%) |
| Dec 2019 | -$35.00 K | $0.00(0.0%) | -$35.00 K(-100.8%) |
| Sept 2019 | - | $0.00(-100.0%) | $4.42 M(-68.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$26.00 K(+188.9%) | $14.11 M(+2.0%) |
| Mar 2019 | - | -$9000.00(-100.2%) | $13.84 M(-3.2%) |
| Dec 2018 | $14.30 M(+219.9%) | $4.46 M(-54.0%) | $14.30 M(+182.7%) |
| Sept 2018 | - | $9.69 M(-3351.0%) | $5.06 M(-134.9%) |
| June 2018 | - | -$298.00 K(-166.1%) | -$14.50 M(+127.9%) |
| Mar 2018 | - | $451.00 K(-109.4%) | -$6.36 M(-242.3%) |
| Dec 2017 | $4.47 M(-82.5%) | -$4.78 M(-51.5%) | $4.47 M(-90.0%) |
| Sept 2017 | - | -$9.87 M(-225.9%) | $44.64 M(-22.5%) |
| June 2017 | - | $7.84 M(-30.5%) | $57.61 M(+56.6%) |
| Mar 2017 | - | $11.28 M(-68.1%) | $36.78 M(+44.3%) |
| Dec 2016 | $25.48 M(-155.3%) | $35.39 M(+1043.3%) | $25.48 M(-576.7%) |
| Sept 2016 | - | $3.10 M(-123.8%) | -$5.35 M(-90.9%) |
| June 2016 | - | -$12.99 M(>+9900.0%) | -$58.93 M(+27.9%) |
| Mar 2016 | - | -$13.00 K(-100.3%) | -$46.07 M(-0.0%) |
| Dec 2015 | -$46.09 M(+4550.7%) | $4.56 M(-109.0%) | -$46.09 M(-9.3%) |
| Sept 2015 | - | -$50.49 M(>+9900.0%) | -$50.79 M(>+9900.0%) |
| June 2015 | - | -$126.00 K(+306.5%) | -$470.00 K(-54.0%) |
| Mar 2015 | - | -$31.00 K(-78.8%) | -$1.02 M(+3.0%) |
| Dec 2014 | -$991.00 K | -$146.00 K(-12.6%) | -$991.00 K(+17.3%) |
| Sept 2014 | - | -$167.00 K(-75.3%) | -$845.00 K(+24.6%) |
| June 2014 | - | -$677.00 K(>+9900.0%) | -$678.00 K(>+9900.0%) |
| Mar 2014 | - | -$1000.00 | -$1000.00 |
FAQ
- What is Cidara Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Cidara Therapeutics?
- What is Cidara Therapeutics annual CFI year-on-year change?
- What is Cidara Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly CFI year-on-year change?
- What is Cidara Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cidara Therapeutics?
- What is Cidara Therapeutics TTM CFI year-on-year change?
What is Cidara Therapeutics annual cash flow from investing activities?
The current annual CFI of CDTX is -$505.00 K
What is the all time high annual CFI for Cidara Therapeutics?
Cidara Therapeutics all-time high annual cash flow from investing activities is $25.48 M
What is Cidara Therapeutics annual CFI year-on-year change?
Over the past year, CDTX annual cash flow from investing activities has changed by -$387.00 K (-327.97%)
What is Cidara Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of CDTX is -$106.00 K
What is the all time high quarterly CFI for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly cash flow from investing activities is $35.39 M
What is Cidara Therapeutics quarterly CFI year-on-year change?
Over the past year, CDTX quarterly cash flow from investing activities has changed by +$20.00 K (+15.87%)
What is Cidara Therapeutics TTM cash flow from investing activities?
The current TTM CFI of CDTX is -$307.00 K
What is the all time high TTM CFI for Cidara Therapeutics?
Cidara Therapeutics all-time high TTM cash flow from investing activities is $57.61 M
What is Cidara Therapeutics TTM CFI year-on-year change?
Over the past year, CDTX TTM cash flow from investing activities has changed by +$29.00 K (+8.63%)